CytoVale

South San Francisco, CA · Founded 2013 · Privately Held (backing)

Developer of biophysical markers designed to revolutionize diagnostics using cell mechanics and machine learning. CytoVale is based in South San Francisco, CA and was founded in 2013. Its last known valuation is $340 million. It has raised $228 million across 3 recorded rounds; the latest was a $16.4 million debt round in Dec 2020.

Last price · $/share
—
Implied valuation
$340.0M
Total raised
$228.2M
Last round
Debt
Dec 2020
No prints on record

No secondary trades in CytoVale shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CytoVale with a free account
  • ·The complete investor list: 35 names
  • ·Watch CytoVale: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where CytoVale prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of CytoVale stock.